Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.160.25EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.25EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.25ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.25ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.25EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.25EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.25ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.25ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.1.5.74EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.1.5.74EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.1.5.74ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.1.5.74ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.1.5.74EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.74EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.74ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.74ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
XBB.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
XBB.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
XBB.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
XBB.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
XBB.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BN.2.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
BN.2.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BN.2.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
BN.2.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BN.2.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BN.2.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BN.2.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BN.2.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
N.4EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
N.4EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
N.4ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
N.4ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
N.4EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
N.4EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
N.4ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
N.4ENiu-ECACGTTAACAATATTGCAGC20402639126372R-17710.7China
AM.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AM.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AM.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AM.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AM.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AM.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AM.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AM.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AY.15 (Delta)EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AY.15 (Delta)EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used